Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

973 studies match

clinicaltrialsPublishedShowing 101–150 of 973 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04663347	Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)(EPCORE™ NHL-2)	active not recruiting	Phase 1 / Phase 2	543	GenmabINDUSTRY	13	Sep 9, 2026	clinicaltrials
NCT05361395	First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)	active not recruiting	Phase 1	184	AmgenINDUSTRY	15	Sep 9, 2026